FIA
GSK icon

FNY Investment Advisers’s GSK GSK Stock Holding History

FNY Investment Advisers’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$4K – 914
2025
Q4 		$4K Buy
+100
New +$4.66K ﹤0.01% 753
2024
Q1 		– Sell
-200
Closed -$7K – 739
2023
Q4 		$7K Sell
200
-100
-33% -$3.59K 0.01% 333
2023
Q3 		$10K Sell
300
-200
-40% -$7.1K 0.01% 387
2023
Q2 		$17K Buy
500
+200
+67% +$7.17K 0.02% 261
2023
Q1 		$10K Hold
300
– – 0.01% 338
2022
Q4 		$10K Buy
+300
New +$9.99K 0.01% 311
2022
Q3 		– Sell
-5,520
Closed -$300K – 721
2022
Q2 		$300K Buy
+5,520
New +$305K 0.22% 73
2019
Q4 		– Sell
-8,000
Closed -$426K – 909
2019
Q3 		$426K Buy
+8,000
New +$412K 0.13% 100

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FNY Investment Advisers's GSK Position: Q1 2026 in Review

FNY Investment Advisers sold out of GSK (GSK) in Q1 2026, closing a stake of 100 shares — an estimated $4K sold.

FNY Investment Advisers first reported a position in GSK in Q3 2019 and held it in 8 quarters. The position peaked at $426K in Q3 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • FNY Investment Advisers reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 100 GSK shares in Q1 2026, an estimated $4K.
  • FNY Investment Advisers first reported a position in GSK in Q3 2019 and held it in 8 quarters.
  • FNY Investment Advisers's GSK position peaked at $426K in Q3 2019.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on FNY Investment Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.